<?xml version="1.0" encoding="UTF-8" ?>

        <rss version="2.0">
            <channel>
                <title>Global Fund Sourcing &amp; Management of Health Products Updates</title>
                <description>Updates on sourcing and management of health products from the Global Fund to Fight AIDS, Tuberculosis and Malaria.</description>
                <link>http://www.theglobalfund.org/data/rss-feeds/sourcing/</link>
                        <item>
                            <title>Placing Orders and Procuring Health Products for 2022 </title><link>http://www.theglobalfund.org/en/sourcing-management/updates/2021-11-05-placing-orders-and-procuring-health-products-for-2022/</link><description>While the Global Fund’s assessment of health product supply disruption has been moderate overall during the past 18 months, supply challenges are increasing as a result of growing international freight capacity constraints. Those challenges are likely to remain through at least 2022.</description><pubDate>Mon, 01 Jan 0001 00:00:00 +00:00</pubDate>
                        </item>
                        <item>
                            <title>Opportunity for Evaluation of Selected Medicines </title><link>http://www.theglobalfund.org/en/sourcing-management/updates/2021-09-27-opportunity-for-evaluation-of-selected-medicines/</link><description>The Global Fund, Stop TB Partnership Global Drug Facility and Unitaid are inviting manufacturers of antiretroviral (HIV/AIDS), antihepatitis B and C, antituberculosis and antimalarial medicines to submit an expression of interest to have their products evaluated by the Expert Review Panel for Pharmaceutical Products.</description><pubDate>Mon, 27 Sep 2021 12:00:00 +00:00</pubDate>
                        </item>
                        <item>
                            <title>Opportunity for Evaluation of Diagnostic Products </title><link>http://www.theglobalfund.org/en/sourcing-management/updates/2021-09-20-opportunity-for-evaluation-of-diagnostic-products/</link><description></description><pubDate>Mon, 20 Sep 2021 12:00:00 +00:00</pubDate>
                        </item>
                        <item>
                            <title>Opportunity for Evaluation of Diagnostic Products </title><link>http://www.theglobalfund.org/en/sourcing-management/updates/2021-08-31-opportunity-for-evaluation-of-diagnostic-products/</link><description>The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD).</description><pubDate>Tue, 31 Aug 2021 12:00:00 +00:00</pubDate>
                        </item>
                        <item>
                            <title>Opportunity for Evaluation of Selected Medicines-Delamanid 50 mg tablets </title><link>http://www.theglobalfund.org/en/sourcing-management/updates/2021-08-11-opportunity-for-evaluation-delamanid-50-mg-tablets/</link><description>Suppliers are informed that an Ad-hoc ERP process has been granted for the following formulation: Name Active: Delamanid, Concentration: 50mg, Formulation: tablets.</description><pubDate>Wed, 11 Aug 2021 12:00:00 +00:00</pubDate>
                        </item>
                        <item>
                            <title>Updated Guide to Global Fund Policies on Procurement and Supply Management of Health Products </title><link>http://www.theglobalfund.org/en/sourcing-management/updates/2021-06-21-updated-guide-to-global-fund-policies-on-procurement-and-supply-management/</link><description></description><pubDate>Mon, 21 Jun 2021 14:27:00 +00:00</pubDate>
                        </item>
                        <item>
                            <title>Placing Orders and Procuring Health Products in 2021 </title><link>http://www.theglobalfund.org/en/sourcing-management/updates/2021-05-07-placing-orders-and-procuring-health-products-in-2021/</link><description>The Global Fund continues to support countries to process requisitions efficiently and ensure products for the three diseases and COVID-19 are delivered as close to the promised dates as possible.</description><pubDate>Fri, 07 May 2021 12:00:00 +00:00</pubDate>
                        </item>
                        <item>
                            <title>Global Fund Finalizes Procurement Service Agent Fees </title><link>http://www.theglobalfund.org/en/sourcing-management/updates/2021-02-09-global-fund-finalizes-procurement-service-agent-fees/</link><description></description><pubDate>Tue, 09 Feb 2021 16:55:00 +00:00</pubDate>
                        </item>
                        <item>
                            <title>Update for PRs on Placing Orders and Procuring COVID-19 Products in 2021 </title><link>http://www.theglobalfund.org/en/sourcing-management/updates/2021-01-22-update-for-prs-on-placing-orders-and-procuring-covid-19-products-in-2021/</link><description></description><pubDate>Fri, 22 Jan 2021 12:00:00 +00:00</pubDate>
                        </item>
                        <item>
                            <title>COVID-19 Response: Scaling-Up Testing with Antigen-Detection Diagnostics </title><link>http://www.theglobalfund.org/en/sourcing-management/updates/2020-11-30-covid-19-response-scaling-up-testing-with-antigen-detection-diagnostics/</link><description></description><pubDate>Mon, 30 Nov 2020 12:00:00 +00:00</pubDate>
                        </item>
            </channel>
        </rss>


